Jeffrey C. Pepe - 02 Sep 2022 Form 3 Insider Report for Silverback Therapeutics, Inc. (SPRY)

Role
Interim CEO and GC
Signature
/s/ Jeffrey C. Pepe
Issuer symbol
SPRY
Transactions as of
02 Sep 2022
Net transactions value
$0
Form type
3
Filing time
08 Sep 2022, 17:04:48 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SPRY Common Stock 52,323 02 Sep 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SPRY Stock option (right to buy) 02 Sep 2022 Common Stock 35,407 $1.68 Direct F1
holding SPRY Stock option (right to buy) 02 Sep 2022 Common Stock 22,401 $1.27 Direct F2
holding SPRY Stock option (right to buy) 02 Sep 2022 Common Stock 17,619 $1.27 Direct F3
holding SPRY Stock option (right to buy) 02 Sep 2022 Common Stock 18,268 $1.27 Direct F4
holding SPRY Stock option (right to buy) 02 Sep 2022 Common Stock 26,932 $6.65 Direct F5
holding SPRY Stock option (right to buy) 02 Sep 2022 Common Stock 102,039 $21.00 Direct F6
holding SPRY Stock option (right to buy) 02 Sep 2022 Common Stock 45,000 $4.85 Direct F7
holding SPRY Stock option (right to buy) 02 Sep 2022 Common Stock 28,500 $4.85 Direct F8
holding SPRY Stock option (right to buy) 02 Sep 2022 Common Stock 79,261 $3.15 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vested on August 19, 2020, and the remaining shares will vest monthly thereafter over three years.
F2 25% of the shares subject to the option vested on March 4, 2021, and the remaining shares will vest monthly thereafter over three years.
F3 25% of the shares subject to the option vested on July 1, 2021, and the remaining shares will vest monthly thereafter over three years.
F4 The shares subject to the option will vest in equal monthly installments over the 48 months beginning on October 18, 2020.
F5 The shares subject to the option will vest in equal monthly installments over the 48 months beginning on October 22, 2020.
F6 The shares subject to the option will vest in equal monthly installments over the 48 months beginning on January 3, 2021.
F7 The shares subject to the option will vest in equal monthly installments over the 48 months beginning on March 1, 2022.
F8 25% of the shares subject to the option will vest on February 1, 2023, and the remaining shares will vest monthly thereafter over three years.
F9 The shares subject to the option will vest on May 2, 2023.